floatz AI

floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.

How to Use

Users define their strategic focus (therapeutic area, indication, constraints). floatz then analyzes the opportunity space by combining literature, disease biology, omics data, pathway networks, and competitive intelligence. Finally, floatz curates and shortlists three high-potential targets, providing scientific rationale, referenced data, and expert review in a decision-ready PDF brief within 14 days.

Key Features

• AI-driven drug target identification
• Integration of human genetics, tissue expression, and pathway analysis
• Delivery of 3 clinically-relevant targets in 14 days
• Multi-layered analysis (literature, omics, disease biology, competitive intelligence)
• Expert-reviewed target selection

Use Cases

• Identifying novel drug targets for specific disease areas
• Expanding existing drug programs or exploring new therapeutic spaces
• Informing strategic decision-making or licensing evaluation for drug development